V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330002408 | 330001344 | null | 52.3 | Disease modification (D) | 2013-07-02 | 2013-07-16 | BENDAMUSTINE + RITUXIMAB | null | N | 330008989 | BENDAMUSTINE + RITUXIMAB |
| 330002409 | 330001344 | 1.57 | 73.6 | Palliative (P) | 2016-05-26 | 2016-06-09 | Carboplatin + Etoposide IV 3 day | N | N | 330008989 | CARBOPLATIN + ETOPOSIDE |
| 330002410 | 330001344 | 0 | 70 | Curative (C) | 2017-12-07 | 2017-12-17 | Rituximab | null | null | 330008989 | RITUXIMAB |
| 330002411 | 330001344 | 1.69 | 74.8 | Palliative (P) | 2013-12-20 | 2013-12-20 | Bendamustine+Rituximab(Sub Courses) | N | N | 330008989 | BENDAMUSTINE + RITUXIMAB |
| 330002412 | 330001344 | null | 60.9 | Disease modification (D) | 2014-04-07 | 2014-04-15 | BENDAMUSTINE + RITUXIMAB | 02 | N | 330008989 | BENDAMUSTINE + RITUXIMAB |
| 330002413 | 330001344 | 1.7 | 86 | Disease modification (D) | 2016-03-28 | 2016-04-24 | Carboplatin + Paclitaxel (3 weekly) | N | N | 330008989 | CARBOPLATIN + PACLITAXEL |
| 330002414 | 330001345 | 1.88 | 56.5 | Not known (9) | null | 2015-07-23 | CARBOPLATIN + PACLITAXEL | N | N | 330009013 | CARBOPLATIN + PACLITAXEL |
| 330002415 | 330001345 | 1.6 | 82 | Palliative (P) | 2014-01-04 | 2014-01-09 | BENDAMUSTINE + RITUXIMAB | N | N | 330009013 | BENDAMUSTINE + RITUXIMAB |
| 330002416 | 330001345 | 1.78 | 78 | Neo-adjuvant (N) | 2014-02-10 | 2014-02-10 | Cisplatin + Doxorubicin | 2 | null | 330009013 | CISPLATIN + DOXORUBICIN |
| 330002417 | 330001345 | 1.59 | 72.9 | null | 2013-04-30 | 2013-05-21 | Carboplatin AUC 6 - 10 | 2 | N | 330009013 | CARBOPLATIN |
| 330002418 | 330001345 | 1.58 | 51 | Curative (C) | 2015-05-15 | 2015-05-16 | Cisplatin + Doxorubicin | 2 | N | 330009013 | CISPLATIN + DOXORUBICIN |
| 330002419 | 330001346 | 1.75 | 81 | Neo-adjuvant (N) | 2015-10-06 | 2015-10-09 | Cisplatin + Doxorubicin | N | N | 330009026 | CISPLATIN + DOXORUBICIN |
| 330002420 | 330001347 | 1.8 | null | Palliative (P) | 2014-09-02 | 2014-09-02 | Cisplatin + Doxorubicin | 02 | N | 330009031 | CISPLATIN + DOXORUBICIN |
| 330002421 | 330001347 | 1.6 | 61.7 | Adjuvant (A) | 2017-04-28 | 2017-06-01 | CARBOPLATIN + PACLITAXEL | 02 | N | 330009031 | CARBOPLATIN + PACLITAXEL |
| 330002422 | 330001348 | 1.63 | 73 | Not known (9) | 2013-12-02 | 2013-12-04 | CNS GCT II Germinoma - Carbo Etop | 2 | N | 330009033 | CARBOPLATIN + ETOPOSIDE |
| 330002423 | 330001348 | null | 57.8 | null | null | 2018-02-19 | CARBOPLATIN + ETOPOSIDE | N | N | 330009033 | CARBOPLATIN + ETOPOSIDE |
| 330002424 | 330001348 | 1.48 | 72.2 | Neo-adjuvant (N) | 2013-05-25 | 2013-06-12 | Carboplatin + Etoposide iv&po | N | N | 330009033 | CARBOPLATIN + ETOPOSIDE |
| 330002425 | 330001348 | null | 29.4 | Adjuvant (A) | 2015-10-28 | 2015-10-31 | Bendamustine+Rituximab (1st Course) | N | N | 330009033 | BENDAMUSTINE + RITUXIMAB |
| 330002426 | 330001348 | 1.6 | null | Curative (C) | 2014-11-24 | 2014-12-23 | Rituximab | N | N | 330009033 | RITUXIMAB |
| 330002427 | 330001348 | 1.74 | 69 | Palliative (P) | null | 2014-06-09 | CARBOPLATIN + PACLITAXEL | null | null | 330009033 | CARBOPLATIN + PACLITAXEL |
| 330002428 | 330001349 | 1.65 | 109 | Curative (C) | 2015-02-23 | 2015-03-02 | Carboplatin AUC 6 - 10 | 2 | null | 330009052 | CARBOPLATIN |
| 330002429 | 330001350 | 1.7 | 56.65 | null | 2014-03-01 | 2014-03-03 | BENDAMUSTINE + RITUXIMAB | N | Y | 330009058 | BENDAMUSTINE + RITUXIMAB |
| 330002430 | 330001350 | 1.66 | 89.6 | Palliative (P) | 2013-09-03 | 2013-09-03 | Liposomal Doxorubicin (20mg/m2) | 2 | null | 330009058 | LIPOSOMAL DOXORUBICIN |
| 330002431 | 330001351 | 1.71 | 82.9 | Disease modification (D) | 2014-12-24 | 2014-12-25 | Rituximab | N | null | 330009061 | RITUXIMAB |
| 330002433 | 330001353 | 1.56 | 71 | Adjuvant (A) | 2015-06-18 | 2015-06-28 | Carboplatin + Paclitaxel (3 weekly) | 2 | null | 330009065 | CARBOPLATIN + PACLITAXEL |
| 330002434 | 330006712 | 1.77 | 94.8 | Palliative (P) | 2014-06-12 | 2014-07-02 | BENDAMUSTINE + RITUXIMAB | null | null | 330009071 | BENDAMUSTINE + RITUXIMAB |
| 330002435 | 330001354 | null | 54.4 | Curative (C) | null | 2015-04-07 | CARBOPLATIN + ETOPOSIDE | null | null | 330009075 | CARBOPLATIN + ETOPOSIDE |
| 330002436 | 330001355 | 1.9 | null | Neo-adjuvant (N) | 2017-01-17 | 2017-01-23 | Cisplatin + Doxorubicin | N | N | 330009081 | CISPLATIN + DOXORUBICIN |
| 330002437 | 330001356 | 1.7 | 60.9 | Not known (9) | null | 2016-01-19 | BENDAMUSTINE + RITUXIMAB | N | N | 330009083 | BENDAMUSTINE + RITUXIMAB |
| 330002438 | 330001357 | 1.7 | null | Adjuvant (A) | 2015-08-16 | 2015-08-20 | Carboplatin + Paclitaxel (3 weekly) | null | null | 330009088 | CARBOPLATIN + PACLITAXEL |
| 330002439 | 330001357 | 1.57 | 79 | Neo-adjuvant (N) | 2014-12-29 | 2015-01-10 | Cisplatin + Doxorubicin | null | null | 330009088 | CISPLATIN + DOXORUBICIN |
| 330002440 | 330001357 | 1.77 | 63 | Curative (C) | 2015-12-05 | 2015-12-10 | Cisplatin + Doxorubicin | N | N | 330009088 | CISPLATIN + DOXORUBICIN |
| 330002443 | 330001360 | 1.7 | 75.6 | Palliative (P) | 2014-12-09 | 2014-12-22 | CARBOPLATIN + PACLITAXEL | N | N | 330009101 | CARBOPLATIN + PACLITAXEL |
| 330002444 | 330001360 | 1.63 | 7.5 | Neo-adjuvant (N) | 2015-01-22 | 2015-02-06 | CARBOPLATIN + PACLITAXEL | N | Y | 330009101 | CARBOPLATIN + PACLITAXEL |
| 330002445 | 330001360 | 0 | 80.6 | Curative (C) | 2017-11-16 | 2017-11-21 | Carboplatin AUC 2 - 5 | null | null | 330009101 | CARBOPLATIN |
| 330002446 | 330001360 | 1.7 | 54.6 | Curative (C) | 2016-07-12 | 2016-07-15 | Carboplatin AUC 2 - 5 | N | N | 330009101 | CARBOPLATIN |
| 330002447 | 330001360 | 1.82 | 113 | Not known (9) | 2016-01-08 | 2016-01-08 | BENDAMUSTINE + RITUXIMAB | N | N | 330009101 | BENDAMUSTINE + RITUXIMAB |
| 330002448 | 330001361 | 1.57 | 98 | null | null | 2016-09-11 | Cisplatin + Doxorubicin | null | null | 330009110 | CISPLATIN + DOXORUBICIN |
| 330002449 | 330001362 | 0 | 56.8 | Palliative (P) | 2015-06-03 | 2015-06-03 | DOXORUBICIN | 2 | null | 330009113 | DOXORUBICIN |
| 330002450 | 330001362 | 1.62 | 58 | Curative (C) | 2016-05-30 | 2017-02-17 | CNS GCT II Germinoma - Carbo Etop | 2 | Y | 330009113 | CARBOPLATIN + ETOPOSIDE |
| 330002451 | 330009627 | 1.66 | 112 | Palliative (P) | 2014-09-04 | 2014-09-18 | BENDAMUSTINE + RITUXIMAB | null | Y | 330009119 | BENDAMUSTINE + RITUXIMAB |
| 330002452 | 330009627 | null | 93 | Curative (C) | 2017-05-17 | 2017-06-17 | Carboplatin AUC 6 - 10 | N | N | 330009119 | CARBOPLATIN |
| 330002453 | 330001363 | 1.69 | null | Palliative (P) | 2017-09-10 | 2017-09-18 | Cisplatin + Doxorubicin | null | null | 330009124 | CISPLATIN + DOXORUBICIN |
| 330002454 | 330001363 | 1.6 | 0 | Palliative (P) | 2016-09-04 | 2016-09-04 | Carboplatin + Paclitaxel (3 weekly) | y | Y | 330009124 | CARBOPLATIN + PACLITAXEL |
| 330002457 | 330001364 | 1.7 | 70.6 | Palliative (P) | 2016-03-16 | 2016-03-16 | CNS GCT II Germinoma - Carbo Etop | Y | N | 330009138 | CARBOPLATIN + ETOPOSIDE |
| 330002458 | 330006717 | 1.7 | 108.55 | null | 2013-04-23 | 2013-05-09 | Cisplatin + Doxorubicin | N | N | 330009140 | CISPLATIN + DOXORUBICIN |
| 330002459 | 330006717 | 0.52 | 68.6 | Palliative (P) | 2016-08-04 | 2016-08-05 | Rituximab | N | N | 330009140 | RITUXIMAB |
| 330002460 | 330001365 | 1.8 | 86 | Neo-adjuvant (N) | 2015-04-14 | 2015-04-29 | Cisplatin + Doxorubicin | N | N | 330009147 | CISPLATIN + DOXORUBICIN |
| 330002461 | 330001365 | 1.7 | 76.6 | Curative (C) | 2013-08-03 | 2013-08-07 | Liposomal Doxorubicin 40mg/m2 | 02 | N | 330009147 | LIPOSOMAL DOXORUBICIN |
| 330002462 | 330001365 | 1.74 | 63.6 | Curative (C) | 2014-10-07 | 2014-12-01 | Carboplatin AUC 2 - 5 | N | N | 330009147 | CARBOPLATIN |